Pharmaceutical Business review

Forbes Medi-Tech extends license agreement with Pharmavite

The contract calls for Pharmavite’s exclusive rights to Reducol in the US mass-market distribution channel. Pharmavite is expected to support the CholestOff and CholestOff Complete brands through various media channels, public relations and NatureMade.com features.

Laura Wessman, senior vice president, operations at Forbes, said: “Strong CholestOff sales and line extensions have continued to build Pharmavite’s dominant position in the US supplement market with Reducol and we now look forward to being part of their future expansion plans in 2008 and beyond.”